Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Survival and prognostic factors of unresectable pancreatic cancer.

Survival and prognostic factors of unresectable pancreatic cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Survival and prognostic factors of unresectable pancreatic cancer. Abstract Text:

    joo kyung parkJoo Kyung Park,yong bum yoonYong Bum Yoon,yong-tae kimYong-Tae Kim,ji kon ryuJi Kon Ryu,won jae yoonWon Jae Yoon,sang hyub leeSang Hyub Lee,joo kyung parkJoo Kyung Park,yong bum yoonYong Bum Yoon,yong-tae kimYong-Tae Kim,ji kon ryuJi Kon Ryu,won jae yoonWon Jae Yoon,sang hyub leeSang Hyub Lee,joo kyung parkJoo Kyung Park,yong bum yoonYong Bum Yoon,yong-tae kimYong-Tae Kim,ji kon ryuJi Kon Ryu,won jae yoonWon Jae Yoon,sang hyub leeSang Hyub Lee,

    GOALS: The aim of this study was to evaluate the prognostic significance of clinical and laboratory variables, and to investigate survival benefits for different treatment modalities in unresectable pancreatic cancer. BACKGROUND: The majority of pancreatic cancers are found to be unresectable. Therefore, estimations of prognosis and decisions of treatment modalities are important in optimizing the various aspects of care. STUDY: Three hundred and forty unresectable locally advanced, or metastatic pancreatic cancer patients were enrolled from January 1998 to January 2005 at the Seoul National University Hospital. RESULTS: One hundred and five patients received chemotherapy only and 59 patients received concurrent chemoradiotherapy (CCRT). Age, performance status, tumor location, initial CA 19-9 level, American Joint Committee on Cancer stage, and treatment modality (supportive care only, chemotherapy, vs. CCRT) were found to have prognostic significance for overall survival (OS) by univariate analysis, whereas initial CA 19-9 level, stage, and treatment modality were identified as independent prognostic factors by multivariate analysis. In subgroup analysis, stage III patients treated by CCRT (median OS, 10.4 mo) or chemotherapy alone (11.3 mo) showed survival benefit over supportive care (6.4 mo), and stage IV patients treated by chemotherapy alone (6.4 mo) showed survival benefit over supportive care (3.1 mo). CONCLUSIONS: Initial CA 19-9, American Joint Committee on Cancer stage, and treatment modality were independent prognostic factors of OS, and the patients who received chemotherapy or CCRT showed better survival than those who received supportive care only.

    Survival and prognostic factors of unresectable pancreatic cancer. Publishing Authors By Initials

    jk parkJK Park,yb yoonYB Yoon,yt kimYT Kim,jk ryuJK Ryu,wj yoonWJ Yoon,sh leeSH Lee,jk parkJK Park,yb yoonYB Yoon,yt kimYT Kim,jk ryuJK Ryu,wj yoonWJ Yoon,sh leeSH Lee,jk parkJK Park,yb yoonYB Yoon,yt kimYT Kim,jk ryuJK Ryu,wj yoonWJ Yoon,sh leeSH Lee,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Survival and prognostic factors of unresectable pancreatic cancer. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Journal of clinical gastroenterology

    VOLUME: 42

    Page Numbers: 86-91

    Journal Abbreviation: J. Clin. Gastroenterol.

    ISSN: 0192-0790

    DAY: 21

    MONTH: Jan

    YEAR: 2008

    Survival and prognostic factors of unresectable pancreatic cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7910017

    Survival and prognostic factors of unresectable pancreatic cancer. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Survival and prognostic factors of unresectable pancreatic cancer. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Survival and prognostic factors of unresectable pancreatic cancer.

    AFFILIATION: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Clin Gastroenterol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Survival and prognostic factors of unresectable pancreatic cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News